DK499183A - Faste doseringsformer med konstant virkning ved en ikke-ensartet fordeling af aktivt stof - Google Patents

Faste doseringsformer med konstant virkning ved en ikke-ensartet fordeling af aktivt stof Download PDF

Info

Publication number
DK499183A
DK499183A DK499183A DK499183A DK499183A DK 499183 A DK499183 A DK 499183A DK 499183 A DK499183 A DK 499183A DK 499183 A DK499183 A DK 499183A DK 499183 A DK499183 A DK 499183A
Authority
DK
Denmark
Prior art keywords
dosage forms
active substance
uniform distribution
standard dosage
constant effects
Prior art date
Application number
DK499183A
Other languages
Danish (da)
English (en)
Other versions
DK499183D0 (da
Inventor
Michael A Soglio
Original Assignee
Merrell Dow Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharma filed Critical Merrell Dow Pharma
Publication of DK499183D0 publication Critical patent/DK499183D0/da
Publication of DK499183A publication Critical patent/DK499183A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
DK499183A 1982-11-01 1983-10-31 Faste doseringsformer med konstant virkning ved en ikke-ensartet fordeling af aktivt stof DK499183A (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US43810082A 1982-11-01 1982-11-01
US53612883A 1983-09-27 1983-09-27

Publications (2)

Publication Number Publication Date
DK499183D0 DK499183D0 (da) 1983-10-31
DK499183A true DK499183A (da) 1984-05-02

Family

ID=27031546

Family Applications (1)

Application Number Title Priority Date Filing Date
DK499183A DK499183A (da) 1982-11-01 1983-10-31 Faste doseringsformer med konstant virkning ved en ikke-ensartet fordeling af aktivt stof

Country Status (13)

Country Link
EP (1) EP0111144B1 (el)
KR (1) KR900007311B1 (el)
AU (1) AU554377B2 (el)
CA (1) CA1220137A (el)
DE (1) DE3368011D1 (el)
DK (1) DK499183A (el)
ES (1) ES8607008A1 (el)
GR (1) GR78740B (el)
IE (1) IE56182B1 (el)
IL (1) IL70071A (el)
NO (1) NO163356C (el)
NZ (1) NZ206094A (el)
PH (1) PH20332A (el)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE33994E (en) * 1983-08-16 1992-07-14 Burroughs Wellcome Co. Pharmaceutical delivery system
US4624848A (en) * 1984-05-10 1986-11-25 Ciba-Geigy Corporation Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
US4749576A (en) * 1984-05-10 1988-06-07 Ciba-Geigy Corporation Active agent containing hydrogel devices wherein the active agent concentration profile contains a sigmoidal concentration gradient for improved constant release, their manufacture and use
EP0467488B1 (en) * 1984-08-17 1995-10-11 The Wellcome Foundation Limited Composition for the controlled discharge of an active ingredient
US5219575A (en) * 1987-06-26 1993-06-15 Duphar International Research B.V. Compositions with controlled zero-order delivery rate and method of preparing these compositions
EP0297650A1 (en) * 1987-06-26 1989-01-04 Duphar International Research B.V Compositions with controlled zero-order delivery rate and method of preparing these compositions
CN1053570C (zh) * 1987-10-07 2000-06-21 默尔多药物公司 哌啶子基链烷醇的药用组合物-减充血剂复方的制备方法
US4996061A (en) * 1987-10-07 1991-02-26 Merrell Dow Pharmaceuticals Inc. Pharmaceutical composition for piperidinoalkanol-decongestant combination
US4999226A (en) * 1988-06-01 1991-03-12 Merrell Dow Pharmaceuticals Inc. Pharmaceutical compositions for piperidinoalkanol-ibuprofen combination
US5085865A (en) * 1989-04-12 1992-02-04 Warner-Lambert Company Sustained release pharmaceutical preparations containing an analgesic and a decongestant
US5198227A (en) * 1990-01-22 1993-03-30 Mcneil-Ppc, Inc. Dual subcoated simulated capsule medicament
DE69405752T2 (de) * 1993-06-14 1998-02-05 Janssen Pharmaceutica Nv Filmbeschichtete tablette von astemizol und pseudoephedrin mit verlängerter freigabe
US5484607A (en) * 1993-10-13 1996-01-16 Horacek; H. Joseph Extended release clonidine formulation
US5451409A (en) * 1993-11-22 1995-09-19 Rencher; William F. Sustained release matrix system using hydroxyethyl cellulose and hydroxypropyl cellulose polymer blends
US5393765A (en) * 1993-12-13 1995-02-28 Hoffmann-La Roche Inc. Pharmaceutical compositions with constant erosion volume for zero order controlled release
DE19608423A1 (de) * 1996-03-05 1997-09-11 Merck Patent Gmbh Implantate mit phasenweiser Arzneistoffabgabe
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
EP0811374A1 (en) 1996-05-29 1997-12-10 Pfizer Inc. Combination dosage form comprising cetirizine and pseudoephedrine
US6197340B1 (en) 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
DE10031043A1 (de) 2000-06-26 2002-02-14 Bayer Ag Retardzubereitungen von Chinolonantibiotika und Verfahren zu ihrer Herstellung
KR100402053B1 (ko) * 2000-09-28 2003-10-17 한국화학연구원 항생제의 서방성 임플란트 제제
JP4551089B2 (ja) * 2001-10-29 2010-09-22 マサチューセッツ インスティテュート オブ テクノロジー 三次元印刷により製造されたゼロ次放出プロフィール投薬形態のような徐放投薬形態を製造するためのシステム
SA07280459B1 (ar) 2006-08-25 2011-07-20 بيورديو فارما إل. بي. أشكال جرعة صيدلانية للتناول عن طريق الفم مقاومة للعبث تشتمل على مسكن شبه أفيوني
EP2155170A2 (en) 2007-06-08 2010-02-24 Addrenex Pharmaceuticals, Inc. Extended release formulation and method of treating adrenergic dysregulation
CA2991216C (en) 2010-12-22 2020-04-28 Purdue Pharma L.P. Encased tamper resistant controlled release dosage forms
ES2581323T3 (es) 2010-12-23 2016-09-05 Purdue Pharma Lp Formas de dosificación oral sólida resistentes a alteraciones
US10751287B2 (en) 2013-03-15 2020-08-25 Purdue Pharma L.P. Tamper resistant pharmaceutical formulations
WO2016139530A2 (en) * 2015-03-04 2016-09-09 Arnold Forbes Compositions and methods for treating drug addiction

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1139869A (en) * 1966-01-06 1969-01-15 Moore Medicinal Products Ltd Improvements in or relating to tablets
US3965255A (en) * 1974-05-01 1976-06-22 E. E. Eljim Ecology Ltd. Controlled drug releasing preparations
SE418247B (sv) * 1975-11-17 1981-05-18 Haessle Ab Sett att framstella kroppar med reglerad frigoring av en aktiv komponent
US4122157A (en) * 1977-03-04 1978-10-24 Richardson-Merrell Inc. Nitrofurantoin sustained release tablet
GB2042888B (en) * 1979-03-05 1983-09-28 Teijin Ltd Preparation for administration to the mucosa of the oral or nasal cavity
US4291015A (en) * 1979-08-14 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing a vasodilator

Also Published As

Publication number Publication date
NO833961L (no) 1984-05-02
EP0111144B1 (en) 1986-12-03
PH20332A (en) 1986-12-02
IL70071A (en) 1987-12-31
AU2080383A (en) 1984-05-10
DE3368011D1 (en) 1987-01-15
DK499183D0 (da) 1983-10-31
GR78740B (el) 1984-10-02
KR840006765A (ko) 1984-12-03
NO163356C (no) 1990-05-16
KR900007311B1 (ko) 1990-10-08
NZ206094A (en) 1986-10-08
IE56182B1 (en) 1991-05-08
IL70071A0 (en) 1984-01-31
CA1220137A (en) 1987-04-07
IE832543L (en) 1984-05-01
AU554377B2 (en) 1986-08-21
NO163356B (no) 1990-02-05
EP0111144A1 (en) 1984-06-20
ES526901A0 (es) 1986-06-16
ES8607008A1 (es) 1986-06-16

Similar Documents

Publication Publication Date Title
DK499183D0 (da) Faste doseringsformer med konstant virkning ved en ikke-ensartet fordeling af aktivt stof
DK147591C (da) Doseringsenhed til kontrolleret afgivelse af et terapeutisk aktivt stof
DK208685D0 (da) Apparat til afgivelse af flygtigt aktivt stof
GB2049830B (en) Dose determining means of paste dispensers
DK160539C (da) Apparat til inhalering af pulver
DK494782A (da) Kapsel med langvarig frigoerelse af aktivt stof til droevtyggere
DK365382A (da) Fremgangsmaade til fremstilling af en doseringsform med kontrolleret afgivelse
DK316588D0 (da) Sneglefoeder til dosering af pulver
DK35681A (da) Apparat til transportering af faste genstande
DK324385A (da) Farmaceutisk praeparat med kontrolleret frigivelse af det aktive stof
ES497279A0 (es) Procedimiento de inyeccion de cantidades dosificadas de ma- terias pulverulentas e instalacion correspondiente
DK431979A (da) Fremgangsmaade til fremstilling af et stof med bakteriosttisk virkning
DK272383A (da) Farmaceutisk blandingspraeparat med kontrolleret frigivelse af aktivt stof indbefattet maskering af daarlig smag og foroegelse af det aktive stofs stabilitet
DK152831C (da) Fremgangsmaade ved fremstilling af biologisk aktive praeparater med reguleret afgivelse af aktivt stof samt polymerbaseret vaeskeformigt overtraekspraeparat til anvendelse ved fremgangsmaaden
DK155503C (da) Apparat til dosering af pulverformige materialer
FR2529635B1 (fr) Distributeur electromagnetique proportionnel
DK106685A (da) Kontrolleret afgivelse af virksomt stof samt fremgangsmaade til fremstilling deraf
DK6181A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater i tabletform med langvarig afgivelse af det virksomme stof
DK160344C (da) Apparat til portionsvis dosering af et afmaalt rumfang flydende medium
BE876306A (fr) Composant posologique pharmaceutique a liberation maitrisee
DK268783A (da) Insecticide sammensaetninger med hoej koncentration af aktivt stof
DK177085D0 (da) Doseringsanordning ved en injektionssproejte
DK456483D0 (da) Fremgangsmade til fremstilling af dichlorerede derivater af 16alfa-methylpregnanraekken
ES491907A0 (es) Aparato provisto de un conjunto que distribuye dosis de pro-ducto liquido
DK315380A (da) Systemisk insecticidpraeparat med reguleret afgivelse af aktivt stof

Legal Events

Date Code Title Description
AHS Application shelved for other reasons than non-payment